{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:19:47Z","timestamp":1769239187556,"version":"3.49.0"},"reference-count":43,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T00:00:00Z","timestamp":1233792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold>Interferon (IFN)\u2010based combination therapy with ribavirin has become the gold standard for the treatment of chronic hepatitis C virus infection. Haematologic toxicities, such as neutropenia, thrombocytopenia, and anaemia, however, frequently cause poor treatment tolerance, resulting in poor therapeutic efficacy. The aim of this study was to identify host genetic polymorphisms associated with the efficacy or haematologic toxicity of IFN\u2010based combination therapy in chronic hepatitis C patients. We performed comprehensive single nucleotide polymorphism detection in all exonic regions of the 12 genes involved in the IFN signalling pathway in 32 healthy Japanese volunteers. Of 167 identified polymorphisms, 35 were genotyped and tested for an association with the efficacy or toxicity of IFN plus ribavirin therapy in 240 chronic hepatitis C patients. Multiple logistic regression analysis revealed that low viral load, viral genotypes 2 and 3, and a lower degree of liver fibrosis, but none of the genetic polymorphisms, were significantly associated with a sustained virologic response. In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (<jats:italic>IFNAR1<\/jats:italic>10848\u2010A\/G and<jats:italic>STAT2<\/jats:italic>4757\u2010G\/T) were significantly associated with IFN\u2010induced neutropenia (<jats:italic>P\u2003=\u2003<\/jats:italic>0.013 and<jats:italic>P\u2003=\u2003<\/jats:italic>0.011, respectively). Thrombocytopenia was associated with the<jats:italic>IRF7<\/jats:italic>789\u2010G\/A (<jats:italic>P\u2003=\u2003<\/jats:italic>0.031). In conclusion, genetic polymorphisms in IFN signalling pathway\u2010related genes were associated with IFN\u2010induced neutropenia and thrombocytopenia in chronic hepatitis C patients. In contrast to toxicity, the efficacy of IFN\u2010based therapy was largely dependent on viral factors and degree of liver fibrosis.<\/jats:p>","DOI":"10.1111\/j.1365-2893.2009.01095.x","type":"journal-article","created":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T08:53:50Z","timestamp":1233824030000},"page":"388-396","source":"Crossref","is-referenced-by-count":21,"title":["Association of genetic polymorphisms with interferon\u2010induced haematologic adverse effects in chronic hepatitis C patients"],"prefix":"10.1111","volume":"16","author":[{"given":"M.","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Marusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,29]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450107"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360703"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.010"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct061675"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(02)00269-3"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300207"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22347"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/498244"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609954104"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50061"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-005-1558-3"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00898.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20322"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.08.036"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2422"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20139"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.69.6.912"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04078"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1303"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1900"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20031166"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.11.004"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200104"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1142\/S021972000300006X"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1633613100"},{"key":"e_1_2_7_31_2","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried MW","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90173-7"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.076646"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90282-1"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V70.4.1173.1173","article-title":"Effect of recombinant interferons alpha and gamma on human bone marrow\u2010derived megakaryocytic progenitor cells","volume":"70","author":"Ganser A","year":"1987","journal-title":"Blood"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280535"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80113-0"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.01.037"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023668705040"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135308"},{"key":"e_1_2_7_41_2","first-page":"1062","article-title":"Elevated frequency and functional activity of a specific germ\u2010line p53 intron mutation in familial breast cancer","volume":"60","author":"Lehman TA","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-4-200002150-00008"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2000.00233.x"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190505"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2009.01095.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2009.01095.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:38:14Z","timestamp":1738928294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2009.01095.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,29]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1365-2893.2009.01095.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01095.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,29]]}}}